7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Lütfi Özkan, MD Radiation Oncology · Acibadem Bursa Hospital

Prof. Lütfi Özkan, MD

✓ Medically verified profile
Radiation Oncology · Acibadem Bursa Hospital

Prof. Lütfi Özkan, MD

Prof. Lütfi Özkan, MD is a radiation oncologist practicing in the Radiation Oncology unit at Acibadem Bursa Hospital in Bursa, Turkey. His clinical work focuses on radiotherapy and the treatment of breast cancer. He has more than 41 years in medicine, consults in Turkish and English, and offers video consultation for international patients.

Medically verified profile 41+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Özkan → Consultation options Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Prof. Lütfi Özkan, MDAccepting international patients
SpecialtyRadiation Oncology
ConsultationVideo · In person · Second opinion
Profile

About Prof. Lütfi Özkan, MD

Prof. Lütfi Özkan, MD is a radiation oncologist in the Radiation Oncology unit at Acibadem Bursa Hospital in Bursa, Turkey. His clinical work centers on radiotherapy and the treatment of breast cancer. With more than 41 years in medicine, he has practiced in university, public and private hospital settings and joined Acıbadem Healthcare Services in 2023.

Dr. Özkan graduated from Akdeniz University Faculty of Medicine in 1985 and completed his compulsory service as a general practitioner at Siirt Devlet Hospital between 1985 and 1987. He then trained in radiation oncology at Şişli Etfal Training and Research Hospital, completing his specialty training in 1991 and continuing there as chief assistant until 1995. In 1995 he moved to Uludağ University Faculty of Medicine’s Department of Radiation Oncology, where he worked as a specialist and, from 1996, as an assistant professor. He completed a fellowship at the University of Kentucky in 2000, was appointed associate professor in 2002 and professor in 2009, and served in the department as professor until 2015. His later positions include specialist roles at Denizli Onkomer Private Oncology Center (2004–2005), Denizli Private Health Hospital (2015–2018) and Ceylan İnternatiaonal Hospital (2018–2023).

Clinical focus

Dr. Özkan’s practice is focused on radiotherapy, also known as radiation treatment, and on the care of patients with breast cancer. Radiotherapy is one of several treatment options that may be considered for cancer patients, and whether it is appropriate, and in what form, depends on the individual diagnosis, stage and prior treatment. In consultation, Dr. Özkan reviews the patient’s pathology and imaging and discusses the possible role of radiation treatment within the overall treatment plan, in coordination with other specialists involved in the patient’s care.

He has co-authored peer-reviewed publications in journals including Tumori, Hepato-Gastroenterology, Saudi Medical Journal, European Journal of Gynaecological Oncology and Archives of Gynecology and Obstetrics. Topics addressed in these papers include factors influencing axillary node metastasis in breast cancer, carcinoma originating from aberrant breast tissue, synchronous breast cancer in spouses, preoperative and postoperative chemoradiotherapy for locally advanced rectal cancer, and chemoradiotherapy for unresectable locally advanced pancreatic cancer.

How Dr. Özkan works with international patients

Dr. Özkan consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the available options. Video consultation is available for international patients who wish to discuss their case before deciding whether to travel.

Clinical focus

What Dr. Özkan treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Conditions treated

Procedures performed

Background

Education, career and memberships

Education & training

Education

  • 2009Uludağ University / Radyasyon Onkolojisi / Professor
  • 2002Uludağ University / Radyasyon Onkolojisi / Associate Professor
  • 1991Şişli Etfal Training and Research Hospital Radiation Oncology
  • 1985Akdeniz University Faculty of Medicine
Career

Professional Experience

  • 2023Acıbadem Healthcare Services
  • 2018–2023Ceylan İnternatiaonal Hospital / Specialist Doctor
  • 2015–2018Denizli Private Health Hospital / Specialist Dr.
  • 2009–2015UÜTF Radyasyon Onkolojisi Department / Prof. Dr.
  • 2005–2009UÜTF Radyasyon Onkolojisi Department / Doç. Dr.
  • 2004–2005Denizli Onkomer Private Oncology Center / Specialist Dr.
  • 2000University of Kentucky / Fellow
  • 1996–2004UÜTF Radyasyon Onkolojisi Department / Yar. Doç. Dr.
  • 1995–1996UÜTF Department of Radiation Oncology / Specialist Dr.
  • 1991–1995SB Şişli Etfal Hospital, Radyasyon Onkolojisi / Chief Assistant
  • 1987–1991SB Şişli Etfal Hospital, Radiation Oncology / Research Assistant
  • 1985–1987Siirt Devlet Hospital (Zorunlu Hizmet) / Pratisyen Dr.
Selected publications

Selected Publications

  • Carcinoma originating from aberrant breast tissue. A case report and review of the literature Tumori 94(3):440-3 (2008). Cetintas S.K., Turan-Ozdemir S, Topal U, Kurt M, Gokgoz S, Saraydaroglu O, Ozkan L.
  • Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer Hepatogastroenterology 55(85):1158-63 (2008). Kurt M, Ozkan L, Kurt E, Cetintas SK, Aygun S, Ercan I, Yilmazlar T, Memik F.
  • Successful spontaneous pregnancy in a patient with rectal carcinoma treated with pelvic radiotherapy and concurrent chemotherapy: the unique role of laparoscopic lateral ovary transposition Eur J Gyn Oncol 28 (5): 408-410 (2007). Kurt M, Uncu G, Cetintas SK, Kucuk N, Guler S, Ozkan L
  • Synchronous breast cancer in spouses Tumori 92 (3): 244-245 (2006). Cetintas S.K., Kurt M, Gokgoz S, Ozkan L, Engin K, Tasdelen I
  • Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer Tumori 92 (6): 481-486 (2006). Kurt E, Kurt M, Kanat O, Cetintas SK, Aygun S, Palazoglu J, Ozkan L, Evrensel T, Kaya E, Manavoglu O,
  • Factors influencing axillary node metastasis in breast cancer Tumori 92 (5): 416-422 (2006). Cetintas SK, Kurt M, Ozkan L, Engin K, Gokgoz S, Tasdelen I
  • Gastric metastasis of signet ring cell carcinoma of the breast? Saudi Medical Journal, 27 (2), 259-261 (2006). Cetintas SK, Kurt M, Ozkan L, et al.
  • Preoperative chemoradiotherapy in patients with locally advanced rectal cancer Hepato-Gastroenterology, 52,1095-1100 (2005). Kurt M., L. Ozkan, S.K. Cetintas, I. Ercan, A. Zorluoglu, S. Gurel, F. Memik, K. Engin,
  • Postoperative concomittant chemoradiotherapy in patients with locally advanced rectal cancer Hepato-Gastroenterology, 52(65), 1411-1415 (2005). Kurt M., L. Ozkan, T. Yilmazlar, I. Ercan, A. Zorluoglu, F. Memik, K. Engin,
  • Successful salvage therapy of resistant gestational throblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP) Arch Gynecol Obstet 2004, 269, 159-160 Bilgin T., H. Ozan, S. Ozuysal, L. Ozkan,
Good to Know

Frequently Asked Questions

Which conditions and treatments does Dr. Özkan focus on?
Dr. Özkan’s clinical work focuses on radiotherapy, also known as radiation treatment, and on the care of patients with breast cancer. Whether radiotherapy is appropriate for a given patient depends on the diagnosis, stage and previous treatment, and is assessed individually during consultation and in coordination with other specialists.
Where does Dr. Özkan see patients?
Dr. Özkan practices in the Radiation Oncology unit at Acibadem Bursa Hospital in Bursa, Turkey. He joined Acıbadem Healthcare Services in 2023 after earlier positions in university, public and private hospitals, including Uludağ University Faculty of Medicine’s Department of Radiation Oncology.
What languages does Dr. Özkan speak?
Dr. Özkan consults in Turkish and English. For international patients who speak other languages, interpreters can be arranged through the Acibadem international patient team so that the consultation and treatment discussion can take place in a language the patient understands.
What should I send for a case review with Dr. Özkan?
It is helpful to provide existing medical reports and imaging, for example MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries. The Acibadem international patient team coordinates the collection of these documents before the consultation so that prior treatment can be reviewed.
What is Dr. Özkan’s training background?
Dr. Özkan graduated from Akdeniz University Faculty of Medicine in 1985 and completed radiation oncology training at Şişli Etfal Training and Research Hospital in 1991. He completed a fellowship at the University of Kentucky in 2000 and became associate professor in 2002 and professor in 2009 at Uludağ University.
Can I have a video consultation with Dr. Özkan before traveling?
Yes, video consultation is available for international patients. It can be used to discuss the patient’s history, existing reports and imaging, and possible treatment options before deciding whether to travel. Any final treatment decision would follow a clinical examination and review at the hospital.
Where

Hospitals

Departments

Medical Units

Treatments

Treatment guides

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.